NKp46+CD3+ cells as a Novel Target for Vaccines Against Bovine TB
The Morrison and Vordermeier laboratories have recently identified a novel NKp46+CD3+ non-conventional T-cell population in cattle and demonstrated that a subset of these cells recognise phosphatidylinositol mannosides (PIMs - a group of membrane bound lipids) from Mb. In this project we propose to i) examine NKp46+CD3+ T-cell responses during a BCG-immunisation/Mb-challenge study so as to gain some insights into the role of lipid-specific T-cells in bTB and ii) explore the breadth of lipids from TB that act as ant...
Buyer
DEPARTMENT FOR ENVIRONMENT FOOD & RURAL AFFAIRS
Value
£258,467
Published
18 Nov 2016
Closes
1 Mar 2016
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Other
Category
Services
Contract starts
31 Mar 2016
Contract ends
3 Mar 2019
CPV classifications
33651000
General anti-infectives for systemic use and vaccines
Lots
Lot default NKp46+CD3+ cells as a Novel Target for Vaccines Against Bovine TB
£258,467
The Morrison and Vordermeier laboratories have recently identified a novel NKp46+CD3+ non-conventional T-cell population in cattle and demonstrated that a subset of these cells recognise phosphatidylinositol mannosides (PIMs - a group of membrane bound lipids) from Mb. In this project we propose to i) examine NKp46+CD3+ T-cell responses during a BCG-immunisa...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
1 Jun 2016
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.